IIC
EVH icon

Integrated Investment Consultants’s Evolent Health EVH Stock Holding History

Integrated Investment Consultants’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,974
Closed -$28K – 341
2018
Q1 		$28K Buy
+1,974
New +$28.3K 0.01% 502
2017
Q3 		$34K Hold
1,900
– – 0.01% 426
2017
Q2 		$48K Buy
+1,900
New +$45.7K 0.02% 396

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Integrated Investment Consultants's EVH Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Evolent Health (EVH) in Q2 2018, closing a stake of 1,974 shares — an estimated $28K sold.

Integrated Investment Consultants first reported a position in EVH in Q2 2017 and held it in 3 quarters. The position peaked at $48K in Q2 2017. 178 funds tracked by Wall St. Rank hold EVH as of Q2 2018.

  • Integrated Investment Consultants reported no remaining Evolent Health position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 1,974 Evolent Health shares in Q2 2018, an estimated $28K.
  • Integrated Investment Consultants first reported a position in Evolent Health in Q2 2017 and held it in 3 quarters.
  • Integrated Investment Consultants's Evolent Health position peaked at $48K in Q2 2017.
  • 178 funds tracked by Wall St. Rank held Evolent Health as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.